Disease
|
Drug/Important Bio-Agent (IBA)
| 2 | 9- (hydroxymethyl)- 3- (1- adamantyl)hexahydrocannabinolIBA
02/2013
-
01/2013 |
| 2 | Mesylates (Mesylate)IBA
02/2013
-
01/2013 |
| 1 | SCH 23390IBA
02/2013 |
| 1 | RimonabantIBA
02/2013 |
| 1 | Opioid Analgesics (Opioids)IBA
02/2013 |
| 1 | quinolineIBA
02/2013 |
| 1 | methanandamideIBA
02/2013 |
| 1 | AM4113IBA
02/2013 |
| 1 | Morphine (MS Contin)FDA LinkGeneric
02/2013 |
| 1 | Naltrexone (ReVia)FDA LinkGeneric
02/2013 |
| 1 | pyrazoleIBA
02/2013 |
| 1 | Dopamine (Intropin)FDA LinkGeneric
02/2013 |
| 1 | Haloperidol (Haldol)FDA LinkGeneric
02/2013 |
| 1 | Methamphetamine (Desoxyn)FDA LinkGeneric
02/2013 |
| 1 | CannabinoidsIBA
01/2013 |
| 1 | 3- (1- hexylcyclobut- 1- yl)- 6a,7,8,9,10,10a- hexahydro- 6,6- dimethyl- 6H- dibenzo(b,d)pyran- 1,9 diolIBA
01/2013 |
| 1 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
01/2013 |
|
Therapy/Procedure
|